Call Mon-Sun:
1 (800) 301-3753

Cymbalta Withdrawal, Tapering Guide & Alternatives

Last Updated on May 1, 2026 by Carol Gillette

Alternative to Meds Editorial Team
Medically Reviewed by Dr Samuel Lee MD

This guide covers Cymbalta withdrawal symptoms, tapering strategies, timelines, and available alternatives. Also included are a number of professional support options for those needing additional care.

Cymbalta (duloxetine) is a powerful drug, that over time changes the way the brain works. Although commonly prescribed, this antidepressant is one of the most difficult to stop, and can lead to extremely difficult withdrawal symptoms. But these can be avoided with careful planning. Find out more.


The most difficult drugs to withdraw from need the BEST care plan possible.
cymbalta withdrawal, taper, alternatives
With a reliable high rate of success clients benefit from our unique philosophy that our programs are based on. For nearly 20 years, clients have been able to find root causes for symptoms, and safely reduce medication without a return of symptoms. The center has helped thousands of patients reach their mental health goals and are now enjoying a much more satisfying quality of life, without relying solely on medication.
15 Years Experience by Professionals Who Understand Your Journey.
Up to 87 ½% Long-Term Success Rate.
Click to Call7 Days a Week

Join Our Information ARMY AND STAY INFORMED
  • This field is for validation purposes and should be left unchanged.
  • By completing this form, you will be added to our mailing list. You may opt out at any time.
  • This field is hidden when viewing the form

Cymbalta Withdrawal Symptoms

be aware of the risks associated with using CymbaltaThe following lists describe the most commonly reported Cymbalta or duloxetine withdrawal symptoms. Less common withdrawal symptoms are noted below, which can be among the most challenging ones of all. Withdrawal symptoms may include both physical and emotional characteristics. A person may experience some or all of these, and the intensity of symptoms can vary greatly over time and from person to person.

Cymbalta is an “SNRI” antidepressant. The drug is thought to target both serotonin and norepinephrine (adrenaline). After taking Cymbalta for a period of time, the central nervous system and brain chemistry become altered, and become accustomed to the presence of the drug. In this period of time, Cymbalta’s mechanisms of action change the way the brain works. So when it is stopped, especially if done abruptly or too fast, there is a great shock to the system and this is what is referred to as “withdrawal.”

IMPORTANT NOTE: There is a particular difficulty in managing Cymbalta or duloxetine withdrawal because the lowest dosage is significant, at 20 mg. Dropping dosage by this amount is an extremely steep reduction. Further along in this article various methods to avoid this problem are discussed.

Common side effects when coming off Cymbalta can include:
  • Flu-like symptoms, i.e., dizziness, nausea, vomiting, headache 6,24,30,32,35
  • Paresthesia, electric-shock sensations, “brain zaps,” prickling skin sensations 6,24,30,32,35,37
  • Irritability 24,30,32-34
  • Nightmares insomnia 6,24,30,32,35,37
  • Anxiety, agitation, panic attacks 32-34
  • Low mood 32
  • Fatigue 35
  • Diarrhea, abdominal pain 32,35,37
  • Brain fog, cognitive impairment, inability to concentrate 37
  • Muscle aches, tremors 35
  • Balance disturbance 30,32
  • Vision problems 35,37
Other side effects of Cymbalta withdrawal are less common, and more challenging:
  • Parkinsonism, extra-pyramidal and other movement disorders 30,32
  • Akathisia 32
  • Seizure 24
  • Withdrawal-induced mania, delirium, hallucinations 30,33,34,37
  • Suicidal thoughts 2,6,32
  • Depersonalization 30

Cymbalta Withdrawal Timeline

Every individual will have their own unique Cymbalta withdrawal timeline. One can however have a sense of how long Cymbalta withdrawal will last. There is no precise cookie-cutter answer, but there are some typical characteristics to expect.

The typical onset of withdrawal is within 24-72 hours. An acute phase follows, estimated at lasting 1-3 weeks. Symptoms that linger longer are called protracted withdrawal which can endure for weeks or months in some cases.

The factors that can affect one’s Cymbalta withdrawal timeline include dosage, length of use, health considerations, and how the withdrawal is managed, i.e., cold turkey or too fast, vs slow and gradual.

Developed Dependence and Tolerance

Research has been historically sparse, concerning patients developing tolerance and dependence on SNRIs like Cymbalta. The consequences and evidence of developing dependence and tolerance is a person suffers withdrawals when the drug is discontinued.

Recent research is successfully bringing these matters to the attention of the medical community. For example, in 2018, Fava et al authored an extensive review of 22 double-blind randomized controlled trials, numerous open trials, and 23 case reports on various types of second-generation antidepressants like Cymbalta. After reviewing these trials and numerous other research papers, the authors found that withdrawal symptoms occurred after ANY SNRI drug was discontinued.36

In contrast, the FDA label for Cymbalta offers one lean sentence on the subject, that recommends gradual discontinuation when possible, rather than abrupt cessation. No other guidelines are given for how to taper off Cymbalta safely.18

How to Taper Off Cymbalta Safely

As mentioned earller, Cymbalta’s lowest dose pill comes in at 20 mg. A person may be taking 20, 40, 60, or greater dosages daily. Unfortunately, you can’t cut Cymbalta capsules with a pill-cutter, because each capsule contains beads. To try and reduce by one capsule is a dramatic reduction. one method of tapering is to count the pelletsGradual tapering is critical for success. There are a number of ways to approach this problem, which should be discussed with your prescriber before implementing.

In order to taper off Cymbalta safely, one may need to open the capsule and count the beads. This way, a gradual reduction is possible. A compounding pharmacy may be able to assist. The rate at which the drug is reduced can vary during the process, and is a point for ongoing discussion with the prescriber you are working with, who knows your history, and who is willing to help you taper off Cymbalta safely. In general terms, a small reduction in dosage should be allowed to settle out before a further reduction, perhaps a week or longer between cuts.

Another approach sometimes used is to convert to an equivalent medication that is available in smaller-sized pills. That could make a small step down easier to accomplish. However, switching medications can prompt other difficulties, so this taper schedule needs very close and careful medical supervision.

Another method sometimes used is introducing a bridge medication or cross-over tapering to soften the withdrawal symptoms, and again needs a discussion with the prescriber to make sure the tapering process is done safely. Read more information on these and other methods of tapering and please share this information with your prescriber.

Whichever tapering schedule is used, an individualized Cymbalta taper plan is essential to soften the harshest withdrawal symptoms and avoid risks of stopping abruptly.

Cymbalta Alternatives

When appropriate, there are very effective medication alternatives for depression and other symptoms. Much research demonstrates clearly a number of natural, non-drug approaches for psychiatric conditions, with some easily accessed examples shown below. These can be used with medical supervision before, during or after one’s medication taper is complete.

Alternatives to duloxetine work in the same way, and can play an important role in the healing journey.

Natural Cymbalta alternatives include:
  • Therapy such as CBT, DBT — these interventions have been shown in clinical trials to be as or more effective in treating depression, with decreased relapse rate and higher quality of life and longevity scores than that of persons treated with medications.21
  • Nutrition — Keto-based, Paleo, or Mediterranean-style food choices are examples that can help avoid sugars and excess refined carbs, and provide a good balance between plant-based and protein-based foods.22
  • evidence-based alternatives to antidepressant medsChoose unprocessed foods, avoid chemical preservatives, artificial sweeteners, and neurotoxic food additives and flavor enhancers.44
  • Support a healthy microbiome — the second brain — with prebiotics, probiotics, yogurt, and fermented foods daily.53
  • Remove toxins from the workplace, in-home exposure, pesticides, cleaners, etc.3
  • Detox the body of toxic accumulations through sauna, and other forms of cleansing, found in clinical trials to improve cardio, muscular and immune health, and to provide pain relief, better sleep, relaxation, stress reduction, and improved mood.45
  • Physical exercise* — stimulates blood flow, releases neurotransmitters, and has been found as or more effective, with therapeutic effects that often last longer than medications to treat depressive symptoms in many random controlled trials.41-43
  • Traditional Chinese therapeutics such as meditation, acupuncture, yoga, Tai Chi, and QiGong, have been shown in clinical trials to be effective alternative treatments for depression, anxiety, stress, and other unwanted symptoms including chronic pain.54-56
  • Exposure to sunlight or bright light therapy can have dramatic positive effects on mood.5
  • Supplements such as SAMe, St. John’s Wort, 5-HTP, vitamin D, magnesium, saffron, and Omega-3 fatty acids, are some clinically supported examples.1,2,46-50
  • Get tested for food allergies, and nutritional and hormonal deficiencies, which have been shown to cause symptoms like those for which antidepressants are prescribed.23,51,52
  • Lifestyle changes can include a wide range of potential alternative approaches to symptoms including cutting exposure to stress at work or toxic relationships, practicing mindfulness, introducing improving the sleeping environment, and learned relaxation techniques.

There are a wide range of available treatment options using alternatives to duloxetine or Cymbalta, and the importance of individualized care cannot be overstated.

Our Clinical Approach to Cymbalta Withdrawal

ATMC blends basic principles found in orthomolecular medicine, environmental medicine, and supervised tapering support in a peaceful and serene inpatient facility. This makes a beneficial and highly effective setting for Cymbalta tapering. 

An integrative model of care allows for personalized treatment plans with an emphasis on safety and stabilization. Each client works closely with their care team, comprised of medical doctors, and licensed therapists and caregivers.

Holistic, evidence-based protocols Sedona drug rehabThese supports allow for successful and well-managed Cymbalta withdrawal help and to holistically detox from Cymbalta safely.

Do you wish to watch yourself, or a loved one start living the life you know can be possible? Through the use of antidepressant alternatives, people have found that they can address depression issues without enduring negative antidepressant side effects. Alternative medicine provides an alternative to pharmaceutical psychiatry that only treats depressive symptoms with drugs. Many who opted for pharmaceutical solutions have ‘been there, done that” and found the results to be lacking, or contributed to debilitating consequences.

For decades, those in the field of health have also been frustrated by a rather glaring lack of address to withdrawals from antidepressants. However, recent research findings have recognized that withdrawals may be severe and protracted for some people coming off antidepressants.44,45

But the very good news is that alternative and naturopathic practitioners tend to use the innate wisdom of the body for healing by finding the right combination of therapies, changes in lifestyle, and anything else each different person may require for optimal physical and mental health. The alternative medicine approach focuses on each person uniquely, instead of prescribing a psychiatric prescription to every depressed patient.

Alternative to Meds Center sees each patient as an individual and establishes a unique set of tailored alternatives to suit their specific needs.

When to Seek Professional Help

Always seek professional care if tapering medication is being considered. Seek professional care for severe withdrawal symptoms when they arise. For anyone experience mental health instability or failed taper attempts, or long-term medication dependence, good medical guidance is essential.

1 (800) 301-3753 for Cymbalta Withdrawal & Tapering Help

Cymbalta Withdrawal FAQs

Coming off medication is a personalized matter. Below is a summary of some of the most commonly asked questions we receive from people looking for guidance and advice.

How long does Cymbalta withdrawal last?

Withdrawal duration varies but typically begins within a few days and may last several weeks or longer depending on individual factors.

What is the safest method of Cymbalta tapering?

Gradual tapering under professional guidance is generally recommended to reduce withdrawal severity.

Can Cymbalta tapering be dangerous?

In some cases, symptoms can be severe and require medical supervision. Always seed professional guidance and care to best meet the challenges that may come up so that they can be safely resolved.

Are there natural alternatives to Cymbalta?

Some individuals explore non-pharmaceutical approaches, and these should be evaluated carefully with professional guidance.

Sources:

1. Hoog SL, Cheng Y, Elpers J, Dowsett SA. Duloxetine and pregnancy outcomes: safety surveillance findings. Int J Med Sci. 2013;10(4):413-9. doi: 10.7150/ijms.5213. Epub 2013 Feb 28. PMID: 23471302; PMCID: PMC3590601. [cited 2026 April 29]

2. Spielmans G, Spence-Sing T, Parry P, Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified. Front. Psychiatry, 13 February 2020 [internet] [cited 2026 April 29]

3. Schlenker B, Gratzke C, Reich O, Schorsch I, Seitz M, Stief CG. Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy. Eur Urol. 2006 Jun;49(6):1075-8. doi: 10.1016/j.eururo.2006.01.038. Epub 2006 Feb 6. PMID: 16481094.[cited 2026 April 29]

4. “List of Confused Drug Names” Institute for Safe Medication Practices, [2019 Feb 28, updated July 26, 2023] [cited 2026 April 29]

5. Wang RZ, Vashistha V, Kaur S, Houchens NW. Serotonin syndrome: Preventing, recognizing, and treating it. Cleve Clin J Med. 2016 Nov;83(11):810-817. doi: 10.3949/ccjm.83a.15129. PMID: 27824534. [cited 2026 April 29]

6. James Davies, John Read, A systematic review into the incidence, severity, and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addictive Behaviors Volume 97, 2019, Pages 111-121, ISSN 0306-4603. [cited 2026 April 29]

7. U.S. Department of Health and Human Services FDA Access Data Drug Safety-related Labeling Changes (SrLC) CYMBALTA (NDA-021427) (DULOXETINE HYDROCHLORIDE)  [cited 2026 April 29]

8. Santarsieri D, Schwartz TL. Antidepressant efficacy and side-effect burden: a quick guide for clinicians. Drugs Context. 2015;4:212290. Published 2015 Oct 8. doi:10.7573/dic.212290 [cited 2026 April 29]

9. Smith T, Nicholson RA. Review of duloxetine in the management of diabetic peripheral neuropathic pain. Vasc Health Risk Manag. 2007;3(6):833-844.[cited 2026 April 29]

10. Wickham R. Review of a study of duloxetine for painful chemotherapy-induced peripheral neuropathy.J Adv Pract Oncol. 2013;4(5):361-368.[cited 2026 April 29]

11. StatPearls [Internet] Duloxetine Jaberpreet S. Dhaliwal; Benjamin C. Spurling; Mohammed Molla. Last Update: June 19, 2020. [cited 2026 April 29]

12. Targum SD. Identification and treatment of antidepressant tachyphylaxis.Innov Clin Neurosci. 2014;11(3-4):24-28.[cited 2026 April 29]

13. Siesser WB, Sachs BD, Ramsey AJ, et al. Chronic SSRI treatment exacerbates serotonin deficiency in humanized Tph2 mutant mice.ACS Chem Neurosci. 2013;4(1):84-88. doi:10.1021/cn300127h. [cited 2026 April 29]

14. Ornoy A, Koren G. SSRIs and SNRIs (SRI) in Pregnancy: Effects on the Course of Pregnancy and the Offspring: How Far Are We from Having All the Answers? Int J Mol Sci. 2019 May 14;20(10):2370. doi: 10.3390/ijms20102370. PMID: 31091646; PMCID: PMC6567187.[cited 2026 April 29]

15. Andrade C, Rao NS. How antidepressant drugs act: A primer on neuroplasticity as the eventual mediator of antidepressant efficacy. Indian J Psychiatry. 2010;52(4):378-386. doi:10.4103/0019-5545.74318.[cited 2026 April 29]

16. Korpi ER, den Hollander B, Farooq U, Vashchinkina E, Rajkumar R, Nutt DJ, Hyytiä P, Dawe GS. Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse. Pharmacol Rev. 2015 Oct;67(4):872-1004. doi: 10.1124/pr.115.010967. PMID: 26403687. [cited 2026 April 29]

17. Carter NJ, McCormack PL. Duloxetine: a review of its use in the treatment of generalized anxiety disorder. CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. PMID: 19480470. [cited 2026 April 29]

18. FDA Access Data CYMBALTA® (duloxetine hydrochloride) Delayed-release Capsules.  [cited 2026 April 29]

19. Perahia DG, Bangs ME, Zhang Q, et al. The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports. Drug Healthc Patient Saf. 2013;5:211-219. Published 2013 Nov 25. doi:10.2147/DHPS.S45445.[cited 2026 April 29]

20. Karakaş Uğurlu G, Onen S, Bayındırlı D, Cayköylü A. Acute dystonia after using single dose duloxetine: case report.Psychiatry Investig. 2013;10(1):95-97. doi:10.4306/pi.2013.10.1.95. [cited 2026 April 29]

21. Mermi O, Atmaca M. Duloksetin Kullanımına Bağlı Hipertansiyon: Bir Olgu Sunumu [Duloxetine-Induced Hypertension: A Case Report]. Turk Psikiyatri Derg. 2016 Spring;27(1):67-9. Turkish. PMID: 27369688. [cited 2026 April 29]

22. Wise TN, Perahia DG, Pangallo BA, Losin WG, Wiltse CG. Effects of the antidepressant duloxetine on body weight: analyses of 10 clinical studies.Prim Care Companion J Clin Psychiatry. 2006;8(5):269-278. doi:10.4088/pcc.v08n0503. [cited 2026 April 29]

23. Sansone RA, Sansone LA. Duloxetine-related acute dysphoria.Psychiatry (Edgmont). 2007;4(11):65-68. [cited 2026 April 29]

24. Perahia DG, Kajdasz DK, Desaiah D, Haddad PM. Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder. J Affect Disord. 2005 Dec;89(1-3):207-12. doi: 10.1016/j.jad.2005.09.003. Epub 2005 Nov 2. PMID: 16266753.[cited 2026 April 29]

25. Pangallo BA, Zhang Q, Desaiah D, Perahia DG, Detke MJ, Kennedy SH. Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials. Curr Med Res Opin. 2010 Nov;26(11):2643-51. doi: 10.1185/03007995.2010.522157. Epub 2010 Oct 11. PMID: 20932222. [cited 2026 April 29]

26. Sabljić V, Rakun R, Ružić K, Grahovac T. Duloxetine-related panic attacks. Psychiatr Danub. 2011 Mar;23(1):114-6. PMID: 21448113. [cited 2026 April 29]

27. Akagi H, Kumar TM. Lesson of the week: Akathisia: overlooked at a cost. BMJ. 2002 Jun 22;324(7352):1506-7. doi: 10.1136/bmj.324.7352.1506. PMID: 12077042; PMCID: PMC1123446. [cited 2026 April 29]

28. Horowitz MA, Framer A, Hengartner MP, Sørensen A, Taylor D. Estimating Risk of Antidepressant Withdrawal from a Review of Published Data. CNS Drugs. 2023 Feb;37(2):143-157. doi: 10.1007/s40263-022-00960-y. Epub 2022 Dec 14. PMID: 36513909; PMCID: PMC9911477.[cited 2026 April 29]

29. Qadir A, Haider N. Duloxetine withdrawal seizure.Psychiatry (Edgmont). 2006;3(9):10. [cited 2023 Feb 13]

30. Wilson E, Lader M. A review of the management of antidepressant discontinuation symptoms.Ther Adv Psychopharmacol. 2015;5(6):357-368. doi:10.1177/2045125315612334 [cited 2026 April 29]

31. Acuna C. Duloxetine for the treatment of fibromyalgia. Drugs Today (Barc). 2008 Oct;44(10):725-34. doi: 10.1358/dot.2008.44.10.1269675. PMID: 19137126.[cited 2026 April 29]

32. Warner C, et al., “Antidepressant Discontinuation Syndrome.” published in American Family Physician [online] Aug 1 2006 Issue[cited 2026 April 29]

33. Read J. How common and severe are six withdrawal effects from, and addiction to, antidepressants? The experiences of a large international sample of patients. Addict Behav. 2020 Mar;102:106157. doi: 10.1016/j.addbeh.2019.106157. Epub 2019 Nov 30. PMID: 31841871. [cited 2026 April 29]

34. Ali S, Milev R. Switch to mania upon discontinuation of antidepressants in patients with mood disorders: a review of the literature. Can J Psychiatry. 2003 May;48(4):258-64. doi: 10.1177/070674370304800410. PMID: 12776393. [cited 2026 April 29]

35. Hengartner MP, Schulthess L, Sorensen A, Framer A. Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum. Ther Adv Psychopharmacol. 2020 Dec 24;10:2045125320980573. doi: 10.1177/2045125320980573. PMID: 33489088; PMCID: PMC7768871.[cited 2026 April 29]

36. Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J. Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review. Psychother Psychosom. 2018;87(4):195-203. doi: 10.1159/000491524. Epub 2018 Jul 17. PMID: 30016772.[cited 2026 April 29]

37. White P, Faingold CL. Emergent Antidepressant Discontinuation Syndrome Misdiagnosed as Delirium in the ICU. Case Rep Crit Care. 2019;2019:3925438. Published 2019 Aug 4. doi:10.1155/2019/3925438 [cited 2026 April 29]

38. Skljarevski V, Desaiah D, Liu-Seifert H, Zhang Q, Chappell AS, Detke MJ, Iyengar S, Atkinson JH, Backonja M. Efficacy and safety of duloxetine in patients with chronic low back pain. Spine (Phila Pa 1976). 2010 Jun 1;35(13):E578-85. doi: 10.1097/BRS.0b013e3181d3cef6. PMID: 20461028. [cited 2026 April 29]

39. Horii I. Toxic effect onset and evaluations of medicinal drugs–horizon for Darwinian toxicological thought. J Toxicol Sci. 2010 Aug;35(4):425-35. doi: 10.2131/jts.35.425. PMID: 20686329. [cited 2026 April 29]

40. Urits I, Peck J, Orhurhu MS, Wolf J, Patel R, Orhurhu V, Kaye AD, Viswanath O. Off-label Antidepressant Use for Treatment and Management of Chronic Pain: Evolving Understanding and Comprehensive Review. Curr Pain Headache Rep. 2019 Jul 29;23(9):66. doi: 10.1007/s11916-019-0803-z. PMID: 31359175. [cited 2026 April 29]

41. Sloan G, Alam U, Selvarajah D, Tesfaye S. The Treatment of Painful Diabetic Neuropathy. Curr Diabetes Rev. 2022;18(5):42-96. doi: 10.2174/1573399817666210707112413. PMID: 34238163. [cited 2026 April 29]

42. Park K, Kim S, Ko YJ, Park BJ. Duloxetine and cardiovascular adverse events: A systematic review and meta-analysis. J Psychiatr Res. 2020 May;124:109-114. doi: 10.1016/j.jpsychires.2020.02.022. Epub 2020 Feb 27. PMID: 32135389.[cited 2026 April 29]

43. Hengartner M,  Ploderl M,  Newer-generation Antidepressants and Suicide Risk …. published in the Journal of Psychotherapy Psychosomatics [published June 4, 2019] [cited 2026 April 29]

44. NICE Overview Depression in Adults, Guidelines and Treatment published 29 June 2022 [cited 2026 April 29]

45. “NICE updates antidepressant guidelines to reflect severity and length of withdrawal symptoms.”The Pharmaceutical Journal 2019;367:l6103 [cited 2026 April 29]

Originally Published April __, 2026 by Diane Ridaeus


This content has been reviewed and approved by a licensed physician.

Dr. Samuel Lee

Dr. Samuel Lee is a board-certified psychiatrist, specializing in a spiritually-based mental health discipline and integrative approaches. He graduated with an MD at Loma Linda University School of Medicine and did a residency in psychiatry at Cedars-Sinai Medical Center and University of Washington School of Medicine in Seattle. He has also been an inpatient adult psychiatrist at Kaweah Delta Mental Health Hospital and the primary attending geriatric psychiatrist at the Auerbach Inpatient Psychiatric Jewish Home Hospital. In addition, he served as the general adult outpatient psychiatrist at Kaiser Permanente.  He is board-certified in psychiatry and neurology and has a B.A. Magna Cum Laude in Religion from Pacific Union College. His specialty is in natural healing techniques that promote the body’s innate ability to heal itself.

Social Profile: LinkedIn

View Bio

 

Medical Disclaimer:
Nothing on this Website is intended to be taken as medical advice. The information provided on the website is intended to encourage, not replace, direct patient-health professional relationships. Always consult with your doctor before altering your medications. Adding nutritional supplements may alter the effect of medication. Any medication changes should be done only after proper evaluation and under medical supervision.

We Accept Most PPO Insurance Plans for Partial Coverage of Fees

Call Now to Verify BlueCross BlueShield Cigna Aetna

Our Success Stories

Medication Withdrawal Success Stories

Can you imagine being free from medications, addictive drugs, and alcohol? This is our goal and we are proving it is possible every day!

Read All StoriesView All Videos